Healthcare -
Biotechnology - NASDAQ - GB
$ 1.189
-0.917 %
$ 15 M
Market Cap
-0.48
P/E
AKTX - OPERATING INCOME
Operating Income AKTX - Akari Therapeutics, Plc
-16.8 M
LAST VALUE
1.19%
2 YEAR CAGR
3.41%
5 YEAR CAGR
-16.64%
10 YEAR CAGR